- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT03460392
Study of Human Microbiota in Healthy and Pathological Conditions (MicroSP)
The aim of the present study is to characterize the bacterial composition (microbiota) colonizing to the human body in different physio - pathological conditions (lifestyle, motor activity, surgical operations, probiotic and prebiotic consumption, antibiotic therapies, chemotherapeutic therapies), nervous and musculoskeletal diseases, gastrointestinal and metabolic disorders , oral and vaginal diseases, etc.). In particular, they will be investigate:
- the changes in the bacterial abundance
- the potential microbial interactions with the human host
- the microbial networks describing on the bacterial interactions within a specific composition of the human microbiota
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
The main objective of this study is to deepen the knowledge about the bacterial communities associated to the human organism. In particular, the present study aims to evaluate how the microbiota (intestinal, cutaneous, vaginal, nasal, bronchial, breast milk, salivary, oral, etc.) is subject to quantitative and qualitative changes consequently to different events involving the human host. The project trys to highlight which microorganisms may be involved in the onset or progression of certain pathological condition, as well as to identify which bacterial genera can be more subject to variations due to specific non-pathological events.
Secondary objectives of this study are:
- To define a "healthy microbiome", that is to understand which are the main bacteria that commonly compose the human microbiome in physiological conditions, differentiating it from that present in certain pathological conditions.
- To characterize the physiological effects that bacterial changes of the human microbiota have on the host.
- To evaluate whether the use of probiotics, prebiotics, dietary and nutritional factors, cosmetics, and oral, nasal, vaginal, or pharmacological therapies of any kind can influence the microbial network of the human microbiota associated to different body districts.
Studietype
Registrering (Forventet)
Kontakter og plasseringer
Studiesteder
-
-
MI
-
Milan, MI, Italia, 20161
- IRCCS Istituto Ortopedico Galeazzi
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
For each cohoort 15 healthy subjects will be enrolled (controls), for a total of 90 subjects.
The study involves the recruitment of 180 subjects (90 pathological and 90 healthy and recruited
Beskrivelse
Inclusion Criteria:
- subjects suffering from neurological/behavioral diseases;
- subjects suffering of bone diseases;
- subjects affected of dysmetabolic / or endocrine disorders;
- subjects with physical activities at a competitive level;
- subjects affected of gastrointestinal disorders;
- subjects with prolonged antibiotic therapies and undergoing surgery
Exclusion Criteria:
- no use of probiotics in the month prior the sampling;
- no use of antibiotics in the month prior the sampling;
- no consumption of yogurt in the month prior the sampling;
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
---|---|
Neurological and behavioral disorders
Subjects with neurological or behavioral disorders such as Tourette syndrome are enrolled.
|
To evaluate the effects of a specific event (i.e.
surgical operation) or therapy (i.e antibiotic treatment) over time;
Andre navn:
|
Subjects affected by bone diseases
Subjects affected by bone diseases such as infective osteomyelitis or osteoporosis are enrolled.
|
To evaluate the effects of a specific event (i.e.
surgical operation) or therapy (i.e antibiotic treatment) over time;
Andre navn:
|
Dysmetabolic and/or endocrine disorders
Patients with endocrine disorders, such as thyroid disfunctions, or with metabolic disorders, including diabetes mellitus,are enrolled.
|
|
Subjects performing agonistic activity
Subjects performing physical activity at agonistic level are enrolled.
|
|
Gastroenteric disorders
Subjects affected by gastric and/or enteric disorders are enrolled.
|
|
Prolonged antibiotic therapy
Patients subjected to prolonged antibiotic therapies and undergone a variety of surgical procedures are enrolled.
|
To evaluate the effects of a specific event (i.e.
surgical operation) or therapy (i.e antibiotic treatment) over time;
Andre navn:
|
Healthy subjects
Subjects without any known ongoing disease are enrolled.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Bacterial abundances calculated by mean of Operational Taxonomic Unit (OTU) count
Tidsramme: Up to 24 weeks
|
It is a measure of the bacterial amount
|
Up to 24 weeks
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Chao's indices estimated on the total OTU amount
Tidsramme: Up to 24 weeks
|
It is a measure of bacterial diversity
|
Up to 24 weeks
|
Simpson's index (D) estimated on the total OTU amount
Tidsramme: Up to 24 weeks
|
It is a measure of bacterial diversity
|
Up to 24 weeks
|
Shannon's index estimated on the total OTU amount
Tidsramme: Up to 24 weeks
|
It is a measure of bacterial diversity
|
Up to 24 weeks
|
The OTU abundances will be used to calculate an adjacency matrix based on the Spearman's correlation coefficient (rs) among different bacterial genus
Tidsramme: up to 24 weeks
|
It is a measure of strength of linear association between different bacterial genera
|
up to 24 weeks
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Lorenzo Drago, Prof., IRCCS Galeazzi Orthopedic Institute, Milan, Italy
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Forventet)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- MiscoSP
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Mikrobiell kolonisering
-
Assistance Publique - Hôpitaux de ParisFullførtOrofaryngeal Gram-negative Bacilli ColonizationFrankrike
-
Assistance Publique - Hôpitaux de ParisFullførtOrofaryngeal Gram-negative Bacilli ColonizationFrankrike
Kliniske studier på Antibiotic therapy
-
Tan Tock Seng HospitalNational Healthcare Group Polyclinics; Temasek PolytechnicFullførtAntimikrobiell resistensSingapore
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)RekrutteringPerifer nevropatiForente stater
-
VA Pacific Islands Health Care SystemUnited States Department of Defense; Charles River AnalyticsFullførtSinne | Stresslidelser, posttraumatiskForente stater
-
University of OklahomaAvsluttetKateterrelaterte infeksjonerForente stater
-
Douglas MenninWeill Medical College of Cornell University; Kent State UniversityFullførtGeneralisert angstlidelse | Depresjon, angst | Angstlidelser og symptomer | Emosjonell dysfunksjonForente stater
-
Cyberonics, Inc.PRA Health SciencesFullførtEpilepsiNorge, Tyskland, Storbritannia, Belgia, Nederland
-
University of PennsylvaniaAvsluttetTilbakevendende Clostridium Difficile-infeksjonForente stater
-
Utah State UniversityUkjent
-
Loma Linda UniversityRekrutteringDiabetisk nevropati, distal symmetrisk polynevropati (manifestasjon)Forente stater
-
EP SciencesUkjentHjerteelektrofysiologiForente stater